Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Cash from Investing Activities (2020 - 2025)

Sight Sciences has reported Cash from Investing Activities over the past 6 years, most recently at $156000.0 for Q4 2025.

  • Quarterly results put Cash from Investing Activities at $156000.0 for Q4 2025, up 213.87% from a year ago — trailing twelve months through Dec 2025 was -$224000.0 (up 41.82% YoY), and the annual figure for FY2025 was -$224000.0, up 41.82%.
  • Cash from Investing Activities for Q4 2025 was $156000.0 at Sight Sciences, up from -$170000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for SGHT hit a ceiling of $156000.0 in Q4 2025 and a floor of -$342000.0 in Q2 2022.
  • Median Cash from Investing Activities over the past 5 years was -$157000.0 (2021), compared with a mean of -$167526.3.
  • Peak annual rise in Cash from Investing Activities hit 213.87% in 2025, while the deepest fall reached 233.33% in 2025.
  • Sight Sciences' Cash from Investing Activities stood at -$157000.0 in 2021, then increased by 17.83% to -$129000.0 in 2022, then plummeted by 104.65% to -$264000.0 in 2023, then skyrocketed by 48.11% to -$137000.0 in 2024, then soared by 213.87% to $156000.0 in 2025.
  • The last three reported values for Cash from Investing Activities were $156000.0 (Q4 2025), -$170000.0 (Q3 2025), and -$210000.0 (Q2 2025) per Business Quant data.